Cargando…

Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis

Oral submucous fibrosis (OSF) is a pre-cancerous lesion, which is characterized by fibrosis of the oral submucosa. Despite large body of studies focusing on this disease, the molecular mechanisms underlying the progression of OSF remained unclear. In this study, 2-DE-based proteomic approaches were...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Yao, Hou, Xiaohui, Feng, Hui, Liu, Rui, Xu, Hao, Gong, Wang, Deng, Jing, Sun, Chongkui, Gao, Yijun, Peng, Jieying, Wu, Yingfang, Li, Jiang, Fang, Changyun, Chen, Qianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312388/
https://www.ncbi.nlm.nih.gov/pubmed/27533088
http://dx.doi.org/10.18632/oncotarget.11254
Descripción
Sumario:Oral submucous fibrosis (OSF) is a pre-cancerous lesion, which is characterized by fibrosis of the oral submucosa. Despite large body of studies focusing on this disease, the molecular mechanisms underlying the progression of OSF remained unclear. In this study, 2-DE-based proteomic approaches were employed to identify the differently expressed proteins between OSF and normal tissues. In total, 88 proteins were identified with altered expression levels, including CypA. Upregulation of CypA was further validated through immunohistochemistry staining combined with Q-PCR and western blot by using clinical samples. Statistical analyses reveal that CypA expression level is correlated to the progression of OSF. Finally, functional study reveals a pro-proliferative property of CypA in fibroblast cells by using multiple in vitro models. The present data suggest that CypA might be a potential biomarker and therapeutic target for OSF, and will lead to a better understanding of OSF pathogenesis.